XML 126 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Accounting Policies) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Other current assets     $ 105 $ 537
Prepaid expense     100 200
Unbilled receivables       100
Other receivables       200
Impairment of patents $ 6,200 $ 0 $ 304  
Impairment of intangibles $ 6,200      
Impairment of goodwill       6,900
Equity awards, contractual term     10 years  
Deferred revenue     $ 170 $ 217
Options, warrants and conversion rights, common stock callable and antidilutive (in shares)     8,265,584 9,963,886
Pharmacogenomic services        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Deferred revenue     $ 200 $ 200
Patents        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Impairment of patents     $ 300  
Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Equity awards, vesting period     1 year  
Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Equity awards, vesting period     3 years